13F-HR filed by Birchview Capital, LP
Birchview Capital, LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-13, with 60 holding rows worth $107,962,638.
- Accession
- 0001618205-24-000003
- Filer
- CIK 1618205
- Filed
- 2024-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 61 entries on the cover page, a total value of $107,962,638 stated on the cover page (in dollars after the unit check, H1), rows summing to $107,962,638 with VALUE read as dollars as filed, 13F file number 028-16416. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Company | 110122108 | COM | 688,218 | $28,581,696 | dollars as filed | |
| BIODESIX INC | 09075X108 | COM | 5,541,176 | $8,470,945 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 1,551,655 | $7,696,209 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 42,240 | $5,815,181 | dollars as filed | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 158,094 | $4,274,862 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 203,574 | $4,201,767 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 250,400 | $4,069,000 | dollars as filed | |
| OVINTIV INC | 69047Q102 | COM | 74,200 | $3,477,754 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 10,000 | $3,185,500 | dollars as filed | |
| HARROW INC | 415858109 | COM | 150,000 | $3,133,500 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 210,000 | $2,837,100 | dollars as filed | |
| PHREESIA INC | 71944F106 | COM | 114,700 | $2,431,640 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 74,000 | $2,404,260 | dollars as filed | |
| QUIDEL CORP | 74838J101 | COM | 67,619 | $2,246,303 | dollars as filed | |
| MASIMO CORP COM | 574795100 | Stock | 15,280 | $1,924,363 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 320,930 | $1,845,348 | dollars as filed | |
| EQUITRANS MIDSTREAM CORP NPV | 294600101 | COM | 133,050 | $1,726,989 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 48,000 | $1,663,200 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 197,000 | $1,426,280 | dollars as filed | |
| DOCGO INC | 256086109 | COM | 460,000 | $1,421,400 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 50,000 | $1,205,000 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 122,000 | $1,002,840 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 88,000 | $919,600 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 34,000 | $740,180 | dollars as filed | |
| EXXON MOBIL CORP | 30231G102 | COM | 5,849 | $673,332 | dollars as filed | |
| PROGYNY INC COM | 74340E103 | Stock | 22,000 | $629,420 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 30,000 | $583,500 | dollars as filed | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 30,000 | $560,100 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 46,000 | $541,880 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 10,000 | $541,800 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 14,000 | $537,040 | dollars as filed | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 10,000 | $523,600 | dollars as filed | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 270,000 | $467,100 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 469,832 | $407,626 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 15,000 | $399,300 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 2,500 | $395,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 10,000 | $389,900 | dollars as filed | |
| Accelerate Diagnostics | 00430H102 | COM | 325,239 | $380,529 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 10,000 | $376,700 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 20,000 | $348,800 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 20,000 | $342,600 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 4,000 | $322,000 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 7,000 | $319,900 | dollars as filed | |
| BLUEBIRD BIO INC | 09609G100 | COM | 311,200 | $306,283 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 28,000 | $277,760 | dollars as filed | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 7,365 | $255,639 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 40,000 | $247,200 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 12,300 | $232,839 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 40,000 | $199,600 | dollars as filed | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 80,000 | $182,400 | dollars as filed | |
| INHIBRX BIOSCIENCES INC | 45720N103 | COM | 12,110 | $170,586 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 138,176 | $124,483 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 10,000 | $120,000 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 50,000 | $87,000 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 10,000 | $74,800 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 17,833 | $68,657 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 28,800 | $66,528 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 16,000 | $65,440 | dollars as filed | |
| OUTSET MEDICAL INC | 690145107 | COM | 10,000 | $38,500 | dollars as filed | |
| CERO THERAPEUTICS HLDGS INC | 71902K105 | CLASS A COM | 12,972 | $3,879 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001618205-24-000003 | this filing | 2024-08-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001618205-25-000006 | base | 2025-06-30 | acceptance time not in the bulk data set |